Lea J - Search Results

1

Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study.

Lea J, Sharma R, Yang F, Zhu H, Ward ES, Schroit AJ. Lea J, et al. Oncotarget. 2017 Feb 28;8(9):14395-14407. doi: 10.18632/oncotarget.14795. Oncotarget. 2017. PMID: 28122335 Free PMC article. Clinical Trial.

2

A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas.

Thu KL, Papari-Zareei M, Stastny V, Song K, Peyton M, Martinez VD, Zhang YA, Castro IB, Varella-Garcia M, Liang H, Xing C, Kittler R, Milchgrub S, Castrillon DH, Davidson HL, Reynolds CP, Lam WL, Lea J, Gazdar AF. Thu KL, et al. Among authors: lea j. Oncotarget. 2016 Jun 10;8(31):50489-50499. doi: 10.18632/oncotarget.9929. eCollection 2017 Aug 1. Oncotarget. 2016. PMID: 28881577 Free PMC article.

3

Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancer.

Manders DB, Kishore HA, Gazdar AF, Keller PW, Tsunezumi J, Yanagisawa H, Lea J, Word RA. Manders DB, et al. Among authors: lea j. Oncotarget. 2018 Feb 14;9(18):14251-14267. doi: 10.18632/oncotarget.24484. eCollection 2018 Mar 6. Oncotarget. 2018. PMID: 29581841 Free PMC article.

4

Biophysicochemical motifs in T cell receptor sequences as a potential biomarker for high-grade serous ovarian carcinoma.

Ostmeyer J, Lucas E, Christley S, Lea J, Monson N, Tiro J, Cowell LG. Ostmeyer J, et al. Among authors: lea j. PLoS One. 2020 Mar 5;15(3):e0229569. doi: 10.1371/journal.pone.0229569. eCollection 2020. PLoS One. 2020. PMID: 32134923 Free PMC article.

5

Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.

Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL, Miller DS, Schorge JO. Lea JS, et al. Gynecol Oncol. 2002 Jan;84(1):115-9. doi: 10.1006/gyno.2001.6473. Gynecol Oncol. 2002. PMID: 11748986

6

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

7

Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.

Bull Phelps SL, Carbon J, Miller A, Castro-Rivera E, Arnold S, Brekken RA, Lea JS. Bull Phelps SL, et al. Among authors: lea js. Am J Obstet Gynecol. 2009 Feb;200(2):180.e1-7. doi: 10.1016/j.ajog.2008.08.047. Epub 2008 Nov 6. Am J Obstet Gynecol. 2009. PMID: 18992864 Free PMC article.

8

Adnexal masses requiring surgical intervention in women with advanced cervical cancer.

Nagel CI, Thomas SK, Richardson DL, Kehoe SM, Miller DS, Lea JS. Nagel CI, et al. Gynecol Oncol. 2014 Sep;134(3):552-5. doi: 10.1016/j.ygyno.2014.06.032. Epub 2014 Jul 9. Gynecol Oncol. 2014. PMID: 25014542

9

Ovarian involvement in endometrioid adenocarcinoma of uterus.

Lin KY, Miller DS, Bailey AA, Andrews SJ, Kehoe SM, Richardson DL, Lea JS. Lin KY, et al. Among authors: lea js. Gynecol Oncol. 2015 Sep;138(3):532-5. doi: 10.1016/j.ygyno.2015.07.012. Epub 2015 Jul 14. Gynecol Oncol. 2015. PMID: 26186908

10

Cervical Adenocarcinoma: Histopathologic Features From Biopsies to Predict Tumor Behavior.

Rivera-Colon G, Chen H, Niu S, Lucas E, Holloway S, Carrick K, Gwin K, Lea J, Zheng W. Rivera-Colon G, et al. Among authors: lea j. Am J Surg Pathol. 2020 Feb;44(2):247-254. doi: 10.1097/PAS.0000000000001379. Am J Surg Pathol. 2020. PMID: 31567190

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

437 results

Search Page